Annual Working Capital
-$3.38 M
-$40.61 M-109.06%
31 December 2023
Summary:
Aptose Biosciences annual working capital is currently -$3.38 million, with the most recent change of -$40.61 million (-109.06%) on 31 December 2023. During the last 3 years, it has fallen by -$121.64 million (-102.85%). APTO annual working capital is now -102.85% below its all-time high of $118.26 million, reached on 31 December 2020.APTO Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$477.00 K
+$3.03 M+118.69%
30 September 2024
Summary:
Aptose Biosciences quarterly working capital is currently $477.00 thousand, with the most recent change of +$3.03 million (+118.69%) on 30 September 2024. Over the past year, it has dropped by -$6.81 million (-93.46%). APTO quarterly working capital is now -99.63% below its all-time high of $128.50 million, reached on 30 September 2020.APTO Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
APTO Working Capital Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -109.1% | -93.5% |
3 y3 years | -102.8% | -99.5% |
5 y5 years | -124.6% | -98.2% |
APTO Working Capital High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -102.8% | at low | -99.5% | +114.1% |
5 y | 5 years | -102.8% | at low | -99.6% | +114.1% |
alltime | all time | -102.8% | +60.0% | -99.6% | +105.7% |
Aptose Biosciences Working Capital History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $477.00 K(-118.7%) |
June 2024 | - | -$2.55 M(+702.5%) |
Mar 2024 | - | -$318.00 K(-90.6%) |
Dec 2023 | -$3.38 M(-109.1%) | -$3.38 M(-146.3%) |
Sept 2023 | - | $7.29 M(-45.1%) |
June 2023 | - | $13.29 M(-47.9%) |
Mar 2023 | - | $25.51 M(-31.5%) |
Dec 2022 | $37.23 M(-49.4%) | $37.23 M(-19.7%) |
Sept 2022 | - | $46.34 M(-15.6%) |
June 2022 | - | $54.88 M(-15.0%) |
Mar 2022 | - | $64.56 M(-12.2%) |
Dec 2021 | $73.56 M(-37.8%) | $73.56 M(-16.4%) |
Sept 2021 | - | $87.97 M(-9.9%) |
June 2021 | - | $97.60 M(-10.3%) |
Mar 2021 | - | $108.78 M(-8.0%) |
Dec 2020 | $118.26 M(+26.9%) | $118.26 M(-8.0%) |
Sept 2020 | - | $128.50 M(+63.6%) |
June 2020 | - | $78.54 M(-9.3%) |
Mar 2020 | - | $86.56 M(-7.2%) |
Dec 2019 | $93.23 M(+580.6%) | $93.23 M(+249.2%) |
Sept 2019 | - | $26.70 M(-19.2%) |
June 2019 | - | $33.05 M(+125.0%) |
Mar 2019 | - | $14.69 M(+7.2%) |
Dec 2018 | $13.70 M(+36.2%) | $13.70 M(+0.0%) |
Sept 2018 | - | $13.70 M(-17.8%) |
June 2018 | - | $16.66 M(+16.3%) |
Mar 2018 | - | $14.32 M(+42.3%) |
Dec 2017 | $10.06 M(+41.4%) | $10.06 M(+3.4%) |
Sept 2017 | - | $9.73 M(-3.9%) |
June 2017 | - | $10.12 M(+33.9%) |
Mar 2017 | - | $7.56 M(+6.3%) |
Dec 2016 | $7.12 M(-46.7%) | $7.12 M(+7.2%) |
Sept 2016 | - | $6.64 M(-24.4%) |
June 2016 | - | $8.78 M(-18.3%) |
Mar 2016 | - | $10.75 M(-19.4%) |
Dec 2015 | $13.34 M(-46.7%) | $13.34 M(-19.5%) |
Sept 2015 | - | $16.56 M(-16.2%) |
June 2015 | - | $19.76 M(-7.4%) |
Mar 2015 | - | $21.35 M(-25.0%) |
Dec 2014 | $25.04 M(-6.1%) | - |
Sept 2014 | - | $28.48 M(+6.8%) |
May 2014 | $26.68 M(-3546.0%) | $26.68 M(+531.6%) |
Feb 2014 | - | $4.22 M(-575.6%) |
Nov 2013 | - | -$888.20 K(-45.9%) |
Aug 2013 | - | -$1.64 M(+112.2%) |
May 2013 | -$774.20 K(-61.7%) | -$774.20 K(-311.9%) |
Feb 2013 | - | $365.30 K(-77.3%) |
Nov 2012 | - | $1.61 M(-47.9%) |
Aug 2012 | - | $3.08 M(-252.5%) |
May 2012 | -$2.02 M(-1510.6%) | -$2.02 M(+76.8%) |
Feb 2012 | - | -$1.14 M(+714.5%) |
Nov 2011 | - | -$140.40 K(-114.0%) |
Aug 2011 | - | $1.00 M(+597.8%) |
May 2011 | $143.30 K | $143.30 K(-86.1%) |
Feb 2011 | - | $1.03 M(+62.3%) |
Date | Annual | Quarterly |
---|---|---|
Nov 2010 | - | $634.60 K(-128.0%) |
Aug 2010 | - | -$2.26 M(+84.3%) |
May 2010 | -$1.23 M(-85.4%) | -$1.23 M(-433.3%) |
Feb 2010 | - | $368.20 K(-75.9%) |
Nov 2009 | - | $1.53 M(+134.2%) |
Aug 2009 | - | $651.90 K(-107.7%) |
May 2009 | -$8.43 M(-204.2%) | -$8.43 M(+41.5%) |
Feb 2009 | - | -$5.96 M(+40.7%) |
Nov 2008 | - | -$4.23 M(-146.1%) |
Aug 2008 | - | $9.19 M(+13.6%) |
May 2008 | $8.09 M(+38.9%) | $8.09 M(-27.6%) |
Feb 2008 | - | $11.17 M(-19.8%) |
Nov 2007 | - | $13.93 M(-7.4%) |
Aug 2007 | - | $15.05 M(+158.4%) |
May 2007 | $5.82 M(+10.2%) | $5.82 M(-3.7%) |
Feb 2007 | - | $6.05 M(-14.1%) |
Nov 2006 | - | $7.05 M(-50.8%) |
Aug 2006 | - | $14.31 M(+170.8%) |
May 2006 | $5.29 M(-64.1%) | $5.29 M(-18.9%) |
Feb 2006 | - | $6.52 M(-1848.2%) |
Nov 2005 | - | -$372.90 K(-103.2%) |
Aug 2005 | - | $11.71 M(-20.6%) |
May 2005 | $14.74 M(-11.1%) | $14.74 M(+7.7%) |
Feb 2005 | - | $13.69 M(+0.4%) |
Nov 2004 | - | $13.64 M(+5.6%) |
Aug 2004 | - | $12.92 M(-22.1%) |
May 2004 | $16.59 M(+9.1%) | $16.59 M(-25.8%) |
Feb 2004 | - | $22.35 M(-22.6%) |
Nov 2003 | - | $28.88 M(-7.1%) |
Aug 2003 | - | $31.09 M(+104.5%) |
May 2003 | $15.20 M(-34.7%) | $15.20 M(-7.3%) |
Feb 2003 | - | $16.39 M(-7.6%) |
Nov 2002 | - | $17.75 M(-12.9%) |
Aug 2002 | - | $20.37 M(-12.5%) |
May 2002 | $23.29 M(-19.5%) | $23.29 M(-3.3%) |
Feb 2002 | - | $24.08 M(-5.7%) |
Nov 2001 | - | $25.54 M(-6.3%) |
Aug 2001 | - | $27.26 M(-5.7%) |
May 2001 | $28.91 M(-19.9%) | $28.91 M(-9.7%) |
Feb 2001 | - | $32.02 M(-1.6%) |
Nov 2000 | - | $32.55 M(-8.9%) |
Aug 2000 | - | $35.71 M(-1.0%) |
May 2000 | $36.09 M(>+9900.0%) | $36.09 M(+315.6%) |
Feb 2000 | - | $8.68 M(+93.7%) |
Nov 1999 | - | $4.48 M(-1056.9%) |
Aug 1999 | - | -$468.40 K(-445.4%) |
May 1999 | $135.60 K(-94.7%) | $135.60 K(-88.6%) |
Feb 1999 | - | $1.19 M(+30.9%) |
Nov 1998 | - | $911.50 K(-37.4%) |
Aug 1998 | - | $1.46 M(-42.7%) |
May 1998 | $2.54 M(-60.7%) | $2.54 M(-26.2%) |
Feb 1998 | - | $3.44 M(-22.2%) |
Nov 1997 | - | $4.43 M(-22.2%) |
Aug 1997 | - | $5.69 M |
May 1997 | $6.46 M | - |
FAQ
- What is Aptose Biosciences annual working capital?
- What is the all time high annual working capital for Aptose Biosciences?
- What is Aptose Biosciences annual working capital year-on-year change?
- What is Aptose Biosciences quarterly working capital?
- What is the all time high quarterly working capital for Aptose Biosciences?
- What is Aptose Biosciences quarterly working capital year-on-year change?
What is Aptose Biosciences annual working capital?
The current annual working capital of APTO is -$3.38 M
What is the all time high annual working capital for Aptose Biosciences?
Aptose Biosciences all-time high annual working capital is $118.26 M
What is Aptose Biosciences annual working capital year-on-year change?
Over the past year, APTO annual working capital has changed by -$40.61 M (-109.06%)
What is Aptose Biosciences quarterly working capital?
The current quarterly working capital of APTO is $477.00 K
What is the all time high quarterly working capital for Aptose Biosciences?
Aptose Biosciences all-time high quarterly working capital is $128.50 M
What is Aptose Biosciences quarterly working capital year-on-year change?
Over the past year, APTO quarterly working capital has changed by -$6.81 M (-93.46%)